Laboratoires Euromedis Société anonyme Past Earnings Performance
Past criteria checks 3/6
Laboratoires Euromedis Société anonyme's earnings have been declining at an average annual rate of -1.1%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been declining at an average rate of 61.4% per year. Laboratoires Euromedis Société anonyme's return on equity is 82.3%, and it has net margins of 58.5%.
Key information
-1.1%
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment Industry Growth | 21.6% |
| Revenue growth rate | -61.4% |
| Return on equity | 82.3% |
| Net Margin | 58.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Does Laboratoires Euromedis Société anonyme (EPA:ALEMG) Have A Healthy Balance Sheet?
Nov 19
Little Excitement Around Laboratoires Euromedis Société anonyme's (EPA:ALEMG) Revenues
Aug 14Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?
Dec 12Investors Aren't Entirely Convinced By Euromedis Groupe's (EPA:ALEMG) Revenues
Jul 29Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?
Oct 05Euromedis Groupe (EPA:ALEMG) Might Have The Makings Of A Multi-Bagger
Jun 14Under The Bonnet, Euromedis Groupe's (EPA:ALEMG) Returns Look Impressive
Oct 03Euromedis Groupe's (EPA:ALEMG) Earnings Are Of Questionable Quality
Jun 12Has Euromedis Groupe (EPA:ALEMG) Got What It Takes To Become A Multi-Bagger?
Mar 18The Euromedis Groupe (EPA:ALEMG) Share Price Has Gained 173%, So Why Not Pay It Some Attention?
Feb 11Euromedis Groupe's (EPA:ALEMG) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 14
Is Euromedis Groupe (EPA:ALEMG) A Risky Investment?
Dec 19Calculating The Fair Value Of Euromedis Groupe (EPA:ALEMG)
Nov 22Revenue & Expenses Breakdown
How Laboratoires Euromedis Société anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 31 | 18 | 1 | 0 |
| 31 Mar 24 | 34 | 16 | 3 | 0 |
| 31 Dec 23 | 37 | 13 | 4 | 0 |
| 30 Sep 23 | 43 | 4 | 13 | 0 |
| 30 Jun 23 | 50 | -6 | 22 | 0 |
| 31 Mar 23 | 52 | -6 | 24 | 0 |
| 31 Dec 22 | 54 | -6 | 25 | 0 |
| 30 Sep 22 | 62 | -7 | 26 | 0 |
| 30 Jun 22 | 69 | -8 | 26 | 0 |
| 31 Mar 22 | 91 | -3 | 27 | 0 |
| 31 Dec 21 | 112 | 2 | 27 | 0 |
| 30 Sep 21 | 158 | 13 | 28 | 0 |
| 30 Jun 21 | 204 | 23 | 29 | 0 |
| 31 Mar 21 | 199 | 23 | 29 | 0 |
| 31 Dec 20 | 193 | 23 | 28 | 0 |
| 30 Sep 20 | 147 | 12 | 28 | 0 |
| 30 Jun 20 | 100 | 0 | 27 | 0 |
| 31 Mar 20 | 89 | -2 | 27 | 0 |
| 31 Dec 19 | 77 | -4 | 28 | 0 |
| 31 Dec 18 | 76 | -5 | 26 | 0 |
| 31 Jan 18 | 76 | -1 | 32 | 0 |
| 31 Oct 17 | 75 | -1 | 29 | 0 |
| 31 Jul 17 | 74 | 0 | 25 | 0 |
| 30 Apr 17 | 74 | 1 | 18 | 0 |
| 31 Jan 17 | 74 | 1 | 11 | 0 |
| 31 Oct 16 | 74 | 1 | 12 | 0 |
| 31 Jul 16 | 74 | 1 | 12 | 0 |
| 30 Apr 16 | 73 | 2 | 12 | 0 |
| 31 Jan 16 | 72 | 2 | 12 | 0 |
| 31 Oct 15 | 72 | 2 | 12 | 0 |
| 31 Jul 15 | 72 | 2 | 11 | 0 |
| 30 Apr 15 | 71 | 2 | 11 | 0 |
| 31 Jan 15 | 71 | 2 | 11 | 0 |
| 31 Oct 14 | 72 | 2 | 11 | 0 |
| 31 Jul 14 | 72 | 3 | 11 | 0 |
| 30 Apr 14 | 74 | 3 | 11 | 0 |
| 31 Jan 14 | 75 | 2 | 11 | 0 |
Quality Earnings: ALEMG has a large one-off loss of €8.2M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: ALEMG became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ALEMG has become profitable over the past 5 years, growing earnings by -1.1% per year.
Accelerating Growth: ALEMG has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: ALEMG has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.4%).
Return on Equity
High ROE: ALEMG's Return on Equity (82.3%) is considered outstanding.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 20:48 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Laboratoires Euromedis Société anonyme is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephanie Lefebvre | Gilbert Dupont |
| Sandrine Cauvin | Gilbert Dupont |
| Romain Freismuth | Portzamparc BNP Paribas |